retatrutide phase 2 nejm 2023 obesity trial jastreboff Early data for demonstrates exceptional weight loss results, reaching approximately 21% placebo-adjusted weight loss by week 48. This performance significantly exceeds all other leading medications currently under GLP-1 Medications for Weight Loss:

With BCBS, Shapely patients can access medical weight loss support, including virtual visits with licensed providers, dietitian-led coaching, and prescriptions for weight loss medications

GLP-1 has anti-apoptotic effects in vivo , and its promotion of cells expressing the GLP-1 receptor directly resists -cell apoptosis (Drucker, 2003)

Compounded tirzepatide carries the same reflux risk as Zepbound because both activate GLP-1 receptors in the stomach

Best practice involves additional education in obesity medicineunderstanding the pathophysiology of weight regulation, contraindications for weight-loss drugs, monitoring protocols, and nutritional counseling basics

Sermorelin stimulates growth hormone production, helping to boost metabolism and preserve lean muscle mass

Drug class and mechanism Tresiba is a basal insulin analog